Publicly available transcriptomic data revealed that TLR8, but not TLR7, is highly expressed in MDS samples at levels comparable to healthy bone marrow, while expression in AML is generally reduced and heterogeneous. This evidence concerns the gene TLR7 and myelodysplastic syndrome.